Flomics
Liquid biopsies with cell-free RNA. A revolutionary tool for diagnosis, prognosis and patient stratification.
26 employees · est. 2018 · Barcelona, Spain
miRecule, Inc. is the older company (2018 vs 2016).
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Flomics | miRecule, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2016 older |
| Headquarters | ||
| Headquarters | Barcelona, Spain | Gaithersburg, United States |
| Employees | ||
| Employees | 26 | 12 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Seed | Seed |
| Total Funding | ||
| Total Funding | $1.00M | $7.20M |
| Funding Rounds | ||
| Funding Rounds | 1 | 3 |
| Services | ||
| Services | Not tracked yet | Development of RNA therapies for cancer and muscular dystrophy, Creation of antibody RNA conjugate therapeutics, Utilization of genomic and outcome data for therapeutic development, Expansion of strategic collaborations (e.g., with Sanofi) |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with cancer, Patients with muscular dystrophy, Patients suffering from neuromuscular diseases, Healthcare providers specializing in rare genetic diseases |
| Taxonomy | ||
| Taxonomy | Liquid Biopsy, Disease Detection, Bioinformatics Analysis, Genomics Facilities, Biomedical Technology, Cloud Platform, SaaS Model, Medical Diagnostics, Blood Sample Analysis | RNA Therapeutics, First-in-Class Therapies, Head & Neck Squamous Cell Carcinoma, Facioscapulohumeral Muscular Dystrophy, Genomic Patient Data, Tailored Therapeutics, DREAmiR™ Platform, Genetic Alteration Targeting, RNA Therapeutics Development, Antibody RNA Conjugate (ARC), Genomic Medicine, Cancer Therapies, Muscular Dystrophy Therapies, Precision Medicine |
| Website | ||
| Website | flomics.com | mirecule.com |
About Flomics
Flomics Biotech is a biotechnology startup based in Spain that is focused on developing innovative blood-based diagnostic tools for a wide range of complex diseases. The company's slogan - "Liquid biopsies with cell-free RNA. A revolutionary tool for diagnosis, prognosis and patient stratification."...
About miRecule, Inc.
miRecule, Inc., a promising player in the RNA Therapeutics domain, is pioneering first-in-class RNA-based therapies, focusing on conditions such as Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Established in 2016, this United States-based startup op...
We will tell you when either one moves
BounceWatch watches Flomics and miRecule, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Flomics and miRecule, Inc. — by email.
Frequently Asked Questions
Compare Flomics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Flomics on 11 Sep 2024, and miRecule, Inc. on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.